Chemocentryx, Inc.
(NASDAQ : CCXI)

( )
CCXI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.21%202.771.2%$538.23m
GILDGilead Sciences, Inc.
-0.90%75.620.9%$479.42m
BIIBBiogen Inc.
-0.11%338.231.3%$390.35m
CELGCelgene Corporation
0.00%84.281.2%$342.66m
ILMNIllumina, Inc.
0.73%328.963.5%$326.50m
REGNRegeneron Pharmaceuticals, Inc.
0.14%399.062.6%$241.66m
ALXNAlexion Pharmaceuticals, Inc.
0.97%128.942.0%$225.63m
VRTXVertex Pharmaceuticals Incorporated
0.02%185.481.9%$218.83m
SRPTSarepta Therapeutics, Inc.
2.46%141.9916.4%$179.98m
AAgilent Technologies, Inc.
-0.37%67.211.5%$160.39m
BMRNBioMarin Pharmaceutical Inc.
0.06%106.074.4%$146.21m
LGNDLigand Pharmaceuticals Incorporated
-3.73%203.0123.3%$122.43m
VKTXViking Therapeutics, Inc.
-2.62%14.860.9%$115.47m
NKTRNektar Therapeutics
0.24%50.595.6%$107.97m
EXASExact Sciences Corporation
-2.06%66.0525.3%$105.10m

Company Profile

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.